Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARWR [NASD]
Arrowhead Research Corp.
Index- P/E- EPS (ttm)-1.08 Insider Own0.70% Shs Outstand52.92M Perf Week-1.85%
Market Cap309.05M Forward P/E- EPS next Y-0.74 Insider Trans4.51% Shs Float52.40M Perf Month-16.09%
Income-49.90M PEG- EPS next Q-0.24 Inst Own71.80% Short Float25.58% Perf Quarter-60.46%
Sales0.20M P/S1545.26 EPS this Y31.60% Inst Trans-6.05% Short Ratio3.12 Perf Half Y-55.82%
Book/sh3.59 P/B1.63 EPS next Y29.50% ROA-45.70% Target Price17.75 Perf Year-21.29%
Cash/sh3.06 P/C1.91 EPS next 5Y7.33% ROE-49.60% 52W Range5.47 - 27.63 Perf YTD-46.18%
Dividend- P/FCF- EPS past 5Y28.30% ROI-82.60% 52W High-78.86% Beta2.61
Dividend %- Quick Ratio19.70 Sales past 5Y-25.40% Gross Margin- 52W Low6.76% ATR0.39
Employees54 Current Ratio19.70 Sales Q/Q- Oper. Margin- RSI (14)29.52 Volatility6.29% 5.85%
OptionableYes Debt/Eq0.01 EPS Q/Q4.30% Profit Margin- Rel Volume1.08 Prev Close6.16
ShortableYes LT Debt/Eq0.00 EarningsNov 25 AMC Payout- Avg Volume4.29M Price5.84
Recom2.00 SMA20-6.59% SMA50-35.72% SMA200-56.87% Volume4,650,674 Change-5.19%
Oct-09-14Downgrade RBC Capital Mkts Outperform → Sector Perform $35 → $9
Mar-05-14Initiated RBC Capital Mkts Outperform $35
Mar-05-14Initiated Deutsche Bank Buy $45
Feb-26-13Initiated Dawson James Buy $4
Nov-25-14 04:01PM  Arrowhead Reports Fiscal 2014 Year End Financial Results Business Wire -5.19%
03:57PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
07:07AM  Q4 2014 Arrowhead Research Corp Earnings Release - After Market Close CCBN
Nov-24-14 10:00PM  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important December 9, 2014 Deadline in Class Action Filed by Firm - ARWR GlobeNewswire
03:36PM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 Business Wire
Nov-21-14 08:32PM  SHAREHOLDER ALERT: Investigation on Behalf of Arrowhead Research Corporation Investors Announced by Law Offices of Howard G. Smith Business Wire
04:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Arrowhead Research Corporation and Certain Officers - ARWR Marketwired
Nov-19-14 09:52PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Arrowhead Research Corp. To Contact Brower Piven Before The December 9, 2014 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire -6.72%
Nov-18-14 04:01PM  Arrowhead to Report Fiscal 2014 Fourth Quarter and Year End Financial Results Business Wire
07:30AM  Arrowhead Files for Regulatory Permission to Begin Phase 1 Trial of RNAi Therapeutic ARC-AAT Business Wire
Nov-16-14 09:08PM  Arrowhead Research seeks to reassure antsy investors at Los Angeles Times
Nov-14-14 10:05PM  Important Reminder to Shareholders of Arrowhead Research Corporation of Upcoming Lead Plaintiff Deadline on December 9, 2014 GlobeNewswire
01:07PM  Arrowhead to Present at Upcoming Conferences Business Wire
Nov-12-14 12:29PM  ARWR INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR GlobeNewswire
Nov-10-14 06:55PM  Arrowhead CEO: We feel 'great' about the drug at CNBC
05:50PM  Big pharma's liver battle CNBC
03:56PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Arrowhead Research Corporation Marketwired
01:11PM  Hepatitis B next great challenge: Arrowhead CNBC
09:15AM  Arrowhead Presents Data on ARC-520 and ARC-AAT at AASLD The Liver MeetingĀ® 2014 Business Wire
Nov-07-14 03:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead Research Corporation and Certain Officers - ARWR PR Newswire
Nov-06-14 12:32PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit --- A GlobeNewswire
Nov-04-14 08:30AM  Hagens Berman Announces the Filing of a Class Action Lawsuit Against Arrowhead Research Corporation, Inc. (NASDAQ: ARWR) GlobeNewswire
Nov-03-14 09:17AM  Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Arrowhead Research Corp. GlobeNewswire
Oct-31-14 08:38PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Arrowhead Research Corp. (ARWR) to Contact the Firm GlobeNewswire
Oct-27-14 04:49PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR Marketwired
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
07:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Arrowhead Research Corporation of Class Action Lawsuit and Upcoming Deadline -- ARWR GlobeNewswire
Oct-24-14 03:22PM  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important Deadline in Class Action Filed by Firm - ARWR GlobeNewswire
Oct-23-14 10:03AM  Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Arrowhead Research Corporation -- ARWR GlobeNewswire
Oct-22-14 03:52PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Arrowhead Research Corp. To Contact Brower Piven Before The December 9, 2014 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Oct-20-14 12:40PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR GlobeNewswire
Oct-17-14 11:49AM  ARROWHEAD RESEARCH CORP. SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Arrowhead Research Corp. GlobeNewswire -8.12%
09:41AM  5 Stocks Under $10 Set to Soar at TheStreet
Oct-15-14 10:18PM  Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Has Been Filed in the Central District of California Against Arrowhead Research Corporation -- ARWR GlobeNewswire +10.03%
05:23PM  Lifshitz & Miller Law Firm Announces Investigation of Apco Oil & Gas International Inc., Arrowhead Research Corporation, Auxilium Pharmaceuticals, Inc., EveryWare Global, Inc., and Gentiva Health Services, Inc. PR Newswire
04:10PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- AR GlobeNewswire
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm Marketwired
11:22AM  Arrowhead Research Corp. Stockholders Who Suffered Losses in Excess of $100,000 Encouraged to Contact Securities Law Firm about Investigation PR Newswire
Oct-14-14 06:36PM  SHAREHOLDER ALERT: Class Action Lawsuit Against Arrowhead Research Corporation Filed By Glancy Binkow & Goldberg LLP Business Wire
12:45PM  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Arrowhead Research Corporation PR Newswire
11:29AM  Arrowhead Research Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
Oct-13-14 06:38PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Arrowhead Research Corporation and Certain Officers -- ARWR GlobeNewswire -5.34%
06:13PM  Robbins Arroyo LLP: Arrowhead Research Corporation (ARWR) Misled Shareholders According to a Recently Filed Class Action GlobeNewswire
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm PR Newswire
11:14AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 Business Wire
Oct-10-14 05:25PM  EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Arrowhead Research Corp. -- ARWR GlobeNewswire -7.95%
06:05AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Oct-09-14 12:15PM  ARWR: Efficacy of ARC-520 Phase IIa not as Strong as Expected, But the Program Is still Viable Zacks Small Cap Research
11:37AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arrowhead Research Corp. - ARWR PR Newswire
08:30AM  Arrowhead Issues Open Letter to Shareholders Business Wire
07:54AM  ARROWHEAD SHAREHOLDER ALERT -- National Securities Law Firm Announces Investigation Of Arrowhead For Potential Violations Of Federal Securities Laws. Encourages Shareholders To Contact Law Firm For More Information. PR Newswire
06:38AM  Arrowhead Research downgraded by RBC Capital Mkts Briefing.com
01:13AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Arrowhead Research Corp. - ARWR Business Wire
Oct-08-14 05:50PM  [video] Arrowhead oversold: Analyst at CNBC -43.80%
04:47PM  Fed to the rescueagain! Yahoo Finance Blogs
03:52PM  Blame Arrowhead Management Entirely for Today's Epic Collapse at TheStreet
02:32PM  Arrowhead Research Corp Hammered On Drug News; Deutsche Bank Lowers Price Target Benzinga
01:49PM  Midday Losers From October 8 - Arrowhead Research Corp, A10 Networks Inc. And More Benzinga
01:36PM  Merck, Bristol, Arrowhead Prep Hepatitis Studies at Investor's Business Daily
10:38AM  Arrowhead Research Sinks on Disappointing Hepatitis B Drug Data at TheStreet
10:00AM  Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver MeetingĀ® 2014 Business Wire
Oct-07-14 07:30AM  Arrowhead to Present at 10th Annual Meeting of the Oligonucleotide Therapeutics Society Business Wire -7.26%
Oct-06-14 02:28PM  Top 5 Biotech Stocks Over The Past Year Benzinga
Sep-30-14 07:30AM  Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs Business Wire
Sep-19-14 02:00PM  Arrowhead to Present at BioCenturys NewsMakers in the Biotech Industry Conference Business Wire
Sep-11-14 01:47PM  3 Biotech Breakout Charts That Could See More Upside Next Week at TheStreet
Sep-04-14 02:51PM  Arrowhead Research Corp Heads Higher After Breakout Benzinga
Sep-03-14 01:41PM  Arrowhead Research Climbs +8.54% Midday, Is Up Over +50% YTD at TheStreet +6.06%
12:54PM  Arrowhead Research Corp Shares Push Over Resistance Level As Momentum Continues Benzinga
Sep-02-14 10:48AM  5 Stocks Poised for Big Breakouts at TheStreet +5.28%
Aug-26-14 04:02PM  Winners & Losers From Tuesday, August 26 Benzinga +13.10%
02:24PM  Arrowhead Research (ARWR) Stock Rises on High Volume at TheStreet
01:31PM  Nasdaq stocks posting largest percentage increases AP
05:00AM  'Fast Money' Recap: Next Stop, S&P 2,100? at TheStreet
Aug-25-14 05:00PM  [video] $8.3 billion biotech deal at CNBC
Aug-19-14 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
06:30AM  5 Stocks Jumping on Unusual Volume at TheStreet
Aug-18-14 07:30AM  ARWR: Arrowhead Reported Fiscal 2014 Third Quarter Financial Results with a Strong Balance Sheet Zacks Small Cap Research
Aug-12-14 05:11PM  Arrowhead Discloses First Human Hepatitis B Therapy Results at TheStreet
04:05PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 Business Wire
04:00PM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q3 2014 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
Aug-07-14 08:20AM  4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher at 24/7 Wall St.
Aug-04-14 09:55AM  Today's Dead Cat Bounce Stock Is Arrowhead Research (ARWR) at TheStreet
Aug-01-14 08:06AM  Biotech Stock Mailbag: Arrowhead, Catalyst Pharma at TheStreet -5.30%
Jul-31-14 04:05PM  Arrowhead to Report Fiscal 2014 Third Quarter Financial Results Business Wire
09:46AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Perilous Reversal" Stock at TheStreet
Jul-29-14 05:00AM  'Fast Money' Recap: Playing China Through U.S. Stocks at TheStreet +11.47%
Jul-28-14 08:55AM  5 Huge Biotech Catalysts Right Around the Corner for Top Stocks at 24/7 Wall St.
Jul-25-14 08:16AM  Alnylam And Benitec at Seeking Alpha
Jul-24-14 01:59PM  Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock at TheStreet
Jul-22-14 09:50AM  Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A Buying Opportunity? at Seeking Alpha
Jul-10-14 09:46AM  Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock at TheStreet
Jul-09-14 09:47AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +8.07%
05:00AM  'Fast Money' Recap: Waiting for the Dust to Settle at TheStreet
Jul-08-14 05:46PM  [video] Biotech buys right now at CNBC -8.06%
Jun-27-14 07:50AM  Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma PR Newswire
Jun-26-14 11:02AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +5.96%
Jun-25-14 08:45AM  Arrowhead (ARWR): Current Price Does Not Reflect Value Zacks Small Cap Research -5.43%
Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company's product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and Adipotide, which is in Phase I clinical trial for the treatment for obesity and related metabolic disorders. Its platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown, and induces endosomal escape; and Homing Peptides platform, a library of short peptides. The company also develops DPC-enabled RNAi therapeutic, a pre-clinical stage product to treat an undisclosed orphan liver disease. It also has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anzalone Christopher RichardPresident and CEOOct 15Buy6.3216,000101,120260,173Oct 15 05:31 PM
GIVEN DOUGLAS BDirectorSep 26Option Exercise2.192,0004,38022,000Sep 30 05:58 PM
GIVEN DOUGLAS BDirectorSep 26Sale15.242,00030,48020,000Sep 30 05:58 PM
GIVEN DOUGLAS BDirectorAug 15Option Exercise2.015,00010,05025,000Aug 19 05:15 PM
Myszkowski Kenneth AllenCFOAug 15Option Exercise6.3240,000252,850111,500Aug 19 05:15 PM
GIVEN DOUGLAS BDirectorAug 15Sale13.905,00069,50120,000Aug 19 05:15 PM
Myszkowski Kenneth AllenCFOAug 15Sale14.0240,000560,86071,500Aug 19 05:15 PM
McKenney CharlesDirectorJun 09Option Exercise2.3922,00052,48039,220Jun 10 09:28 PM
McKenney CharlesDirectorJun 09Sale14.3222,000315,00517,220Jun 10 09:28 PM
Myszkowski Kenneth AllenCFOFeb 12Option Exercise2.0116,00032,16087,500Feb 12 07:15 PM
Myszkowski Kenneth AllenCFOFeb 12Sale18.7716,000300,29071,500Feb 12 07:15 PM
FRYKMAN EDWARD WDirectorFeb 07Option Exercise10.005,00050,00027,000Feb 10 07:45 PM
FRYKMAN EDWARD WDirectorFeb 07Sale15.983,14850,29623,852Feb 10 07:45 PM